News & Updates

20-year study challenges link between gestational diabetes and ADHD

16 Apr 2024 by

Gestational diabetes mellitus (GDM) is not associated with attention-deficit/hyperactivity disorder (ADHD) in offspring, a 20-year multinational study has shown.

20-year study challenges link between gestational diabetes and ADHD

16 Apr 2024

Concomitant use of antidepressants, oral anticoagulants raises bleeding risk in AF patients

14 Apr 2024 by

Patients with atrial fibrillation (AF) who take oral anticoagulants (OACs) and selective serotonin reuptake inhibitors (SSRIs) at the same time appear to have a higher likelihood of major bleeding.

Concomitant use of antidepressants, oral anticoagulants raises bleeding risk in AF patients

14 Apr 2024

Psilocybin for depression, anxiety holds manageable safety profile

13 Apr 2024

In the treatment of individuals with depression and anxiety, therapeutic single-dose psilocybin appears to be tolerable, with acute adverse effects that are resolved within 48 hours, according to the results of a meta-analyses.

Psilocybin for depression, anxiety holds manageable safety profile

13 Apr 2024

Daytime sleepiness: A hidden cause of behavioural and emotional issues in OSA children

11 Apr 2024 by

Excessive daytime sleepiness (EDS) is a risk factor for behavioural and emotional issues in children with obstructive sleep apnoea (OSA), researchers from the Chinese University of Hong Kong (CUHK) have shown.

Daytime sleepiness: A hidden cause of behavioural and emotional issues in OSA children

11 Apr 2024

Study identifies 24-hour warning signs for suicide attempts among teens

09 Apr 2024

Changes in emotion, cognition, and behaviour over a 24-hour period may tell risk of suicide attempts among adolescents, with suicidal communications and withdrawal from social and other activities identified as key warning signs, according to a study.

Study identifies 24-hour warning signs for suicide attempts among teens

09 Apr 2024

Original New Drug Application Approvals by US FDA (16-31 March 2024)

04 Apr 2024

New drug applications approved by US FDA as of 16-31 March 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2024)

04 Apr 2024

Prenatal topiramate not associated with autism in offspring

02 Apr 2024 by

Prenatal exposure to topiramate does not increase the risk of autism in offspring, a US nationwide cohort study has shown.

Prenatal topiramate not associated with autism in offspring

02 Apr 2024

Alcohol use disorder linked to suicide mortality in men, women

21 Mar 2024

People with alcohol use disorder (AUD) have greater odds of dying by suicide, and this association is consistent in men and women, according to the results of a systematic review and meta-analysis.

Alcohol use disorder linked to suicide mortality in men, women

21 Mar 2024

Vitamin B6 best bet against antipsychotic-induced akathisia

20 Mar 2024 by

Mirtazapine, biperiden, and vitamin B6 are all beneficial in the treatment of antipsychotic-induced akathisia (AIA), with vitamin B6 having the best efficacy and tolerability profile, according to the results of a meta-analysis.

Vitamin B6 best bet against antipsychotic-induced akathisia

20 Mar 2024

Antidepressants improve cognition in people with late-life depression

19 Mar 2024

Use of antidepressant medication may lead to improvements in some areas of cognitive function, such as memory and learning, in individuals with late-life depression (LLD), a study has shown.

Antidepressants improve cognition in people with late-life depression

19 Mar 2024

News & Updates

Filter by Specialty:

Specialty:

20-year study challenges link between gestational diabetes and ADHD

20-year study challenges link between gestational diabetes and ADHD

Concomitant use of antidepressants, oral anticoagulants raises bleeding risk in AF patients

Concomitant use of antidepressants, oral anticoagulants raises bleeding risk in AF patients

Psilocybin for depression, anxiety holds manageable safety profile

Psilocybin for depression, anxiety holds manageable safety profile

Daytime sleepiness: A hidden cause of behavioural and emotional issues in OSA children

Daytime sleepiness: A hidden cause of behavioural and emotional issues in OSA children

Study identifies 24-hour warning signs for suicide attempts among teens

Study identifies 24-hour warning signs for suicide attempts among teens

Original New Drug Application Approvals by US FDA (16-31 March 2024)

Original New Drug Application Approvals by US FDA (16-31 March 2024)

Prenatal topiramate not associated with autism in offspring

Prenatal topiramate not associated with autism in offspring

Alcohol use disorder linked to suicide mortality in men, women

Alcohol use disorder linked to suicide mortality in men, women

Vitamin B6 best bet against antipsychotic-induced akathisia

Vitamin B6 best bet against antipsychotic-induced akathisia

Antidepressants improve cognition in people with late-life depression

Antidepressants improve cognition in people with late-life depression